| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.28B | -3.3% | +2.2% |
| Cost of Revenue | $345.2M | +0.2% | -3.1% |
| Gross Profit | $937.3M | -4.6% | +4.3% |
| R&D Expense | $171.2M | +8.1% | -13.3% |
| SG&A Expense | $108.7M | -1.3% | -6.1% |
| Operating Income | $201.2M | -31.0% | -3.8% |
| Pre-tax Income | $207.0M | -3.9% | +99.7% |
| Income Tax | $34.3M | -27.6% | +216.2% |
| Net Income | $172.7M | +2.7% | +86.0% |
| EPS (Basic) | $0.70 | +4.5% | +100.0% |
| EPS (Diluted) | $0.70 | +6.1% | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.25B | -1.4% | -1.9% |
| Accounts Receivable | $620.7M | -6.7% | +4.7% |
| Current Assets | $2.38B | +1.3% | +10.3% |
| Total Assets | $13.33B | -1.8% | -3.1% |
| Current Liabilities | $2.53B | +1.2% | +0.5% |
| Long-term Debt | $6.21B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $821.0M | — | — |
| Investing Cash Flow | $28.0M | — | — |
| Financing Cash Flow | -$749.4M | — | — |
| -2.7% |
| Stockholders' Equity | $3.96B | -2.0% | -4.0% |